Endocyte, Inc. (ECYT) Tops Q1 EPS by 4c

Endocyte, Inc. (NASDAQ: ECYT) reported Q1 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c